To view the PDF file, sign up for a MySharenet subscription.
Back to PHP SENS
PHPROP:  2,325   +41 (+1.80%)  01/08/2025 19:00

PRIMARY HEALTH PROPERTIES PLC - Public dealing disclosure

Release Date: 01/08/2025 13:19
Code(s): PHP     PDF:  
Wrap Text
Public dealing disclosure

Primary Health Properties PLC
(Incorporated in the United Kingdom)
Company Number: 3033634
LSE Share Code: PHP
JSE Share Code: PHP
ISIN Code: GB00BYRJ5J14
LEI: 213800Y5CJHXOATK7X11
("PHP" or the "Company")

                                                                                                       FORM 8 (DD)

      PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT
        (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)
                      Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

1.      KEY INFORMATION

 (a) Full name of discloser:                                            Richard Howell

 (b) Owner or controller of interests and short positions
     disclosed, if different from 1(a):
     The naming of nominee or vehicle companies is insufficient.
     For a trust, the trustee(s), settlor and beneficiaries must be
     named.
 (c) Name of offeror/offeree in relation to whose relevant              Primary Health Properties PLC
     securities this form relates:
     Use a separate form for each offeror/offeree
 (d) Status of person making the disclosure:                            Person acting in concert with the offeror
     e.g. offeror, offeree, person acting in concert with the           (Primary Health Properties PLC)
     offeror/offeree (specify name of offeror/offeree)
 (e) Date dealing undertaken:                                           31 July 2025

 (f) In addition to the company in 1(c) above, is the discloser         NO
     making disclosures in respect of any other party to the
     offer?
     If it is a cash offer or possible cash offer, state "N/A"

2.      POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror
or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)     Interests and short positions in the relevant securities of the offeror or offeree to which the
        disclosure relates following the dealing

 Class of relevant security:                                  Ordinary Shares of 12.5 pence each

                                                           Interests                        Short positions
                                                       Number               %               Number              %
 (1) Relevant securities owned and/or                  333,571            0.0250              Nil               Nil
     controlled:
 (2) Cash-settled derivatives:

 (3) Stock-settled derivatives (including
     options) and agreements to
     purchase/sell:
                                                       333,571           0.0250
      TOTAL:
All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed
on a Supplemental Form 8 (SBL).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 Class of relevant security in relation to which         Ordinary Shares of 12.5 pence each
 subscription right exists:
 Details, including nature of the rights                 Options in respect of a total of 1,290,631 ordinary
 concerned and relevant percentages:                     shares, representing 0.0966% of undiluted PHP
                                                         share count as a result of the following LTIP awards
                                                         and Sharesave scheme:

                                                         Vesting date 5 March 2025 for 2022 LTIP award in
                                                         respect of 313,745 shares which not yet vested
                                                         subject to scheme rules due to close period at
                                                         vesting date.

                                                         Vesting date 27 February 2026 for 2023 LTIP award
                                                         in respect of 414,874 ordinary shares.

                                                         Vesting date 7 March 2027 for 2024 LTIP award in
                                                         respect of 539,779 ordinary shares.

                                                         Vesting date 1 June 2026 for 2023 Sharesave option
                                                         in respect of 22,233 ordinary shares with and
                                                         exercise price of £0.8096.

3.         DEALINGS BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in
1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

(i)        Party to an offer or person acting in concert (except for a principal trader in the same group as a
           connected adviser)

     Class of relevant              Purchase/sale             Number of securities            Price per unit
         security
 Ordinary shares of            Purchase                      70,745                     £0.961209
 12.5p

(ii)       Principal trader where the sole reason for the connection is that the principal trader is in the
           same group as a connected adviser

      Class of relevant   Purchases/ sales        Total number of      Highest price per      Lowest price per
          security                                   securities        unit paid/received     unit paid/received



(b)        Cash-settled derivative transactions
     Class of relevant      Product               Nature of dealing            Number of         Price per unit
         security          description          e.g. opening/closing a         reference
                            e.g. CFD              long/short position,         securities
                                                increasing/reducing a
                                                   long/short position



(c)        Stock-settled derivative transactions (including options)

(i)        Writing, selling, purchasing or varying

     Class of     Product          Writing,       Number of    Exercise       Type          Expiry     Option
     relevant    description     purchasing,      securities   price per       e.g.          date      money
     security      e.g. call       selling,        to which       unit      American,                   paid/
                    option       varying etc.       option                  European                  received
                                                    relates                    etc.                   per unit



(ii)       Exercise

      Class of relevant        Product             Exercising/             Number of         Exercise price per
          security           description        exercised against          securities               unit
                            e.g. call option



(d)        Other dealings (including subscribing for new securities)

       Class of relevant             Nature of dealing                   Details             Price per unit (if
           security            e.g. subscription, conversion                                   applicable)




4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

 Details of any indemnity or option arrangement, or any agreement or understanding, formal or
 informal, relating to relevant securities which may be an inducement to deal or refrain from dealing
 entered into by the party to the offer or person acting in concert making the disclosure and any other
 person:
 Irrevocable commitments and letters of intent should not be included. If there are no such agreements,
 arrangements or understandings, state "none"

 None.


(b)        Agreements, arrangements or understandings relating to options or derivatives

 Details of any agreement, arrangement or understanding, formal or informal, between the party to the
 offer or person acting in concert making the disclosure and any other person relating to:
 (i) the voting rights of any relevant securities under any option; or
 (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative
      is referenced:
 If there are no such agreements, arrangements or understandings, state "none"

 None.
(c)     Attachments

Are any Supplemental Forms attached?

 Supplemental Form 8 (Open Positions)                                                             NO

 Supplemental Form 8 (SBL)                                                                        NO


 Date of disclosure:                                    31 July 2025

 Contact name:                                          Toby Newman

 Telephone number:                                      +44 (0) 7729 047959


Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure
requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

The Company has a primary listing on the London Stock Exchange and a secondary listing on the JSE Limited.


United Kingdom
01 August 2025
Sponsor: PSG Capital

Date: 01-08-2025 01:19:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.